Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 1/2015

01-02-2015 | Original Article

High-normal 2 h glucose is associated with defects of insulin secretion and predispose to diabetes in Chinese adults

Authors: Ziwei Lin, Jian Zhou, Xiaowen Li, Lige Song, Xuhong Hou, Junling Tang, Chen Wang, Weiping Jia

Published in: Endocrine | Issue 1/2015

Login to get access

Abstract

The purpose of the study was to determine whether impaired beta-cell function exists in Chinese individuals within the normal range of glucose tolerance (NGT), and these individuals are predisposed to diabetes later in life. The cross-sectional study included 843 NGT subjects and 562 isolated impaired glucose tolerance (IGT) patients and the longitudinal study included 1,724 NGT subjects. Insulin secretion was assessed using indices derived from oral glucose tolerance test and adjusted by insulin resistance. NGT subjects were sub-divided into two groups: NGT-l (2hPG < 125 mg/dl) and NGT-h (2hPG 125–140 mg/dl). Normal weight subjects were individuals with BMI < 25 kg/m2, and overweight were with BMI ≥ 25 kg/m2. In normal weight subjects, the first- and second-phase insulin secretion indices were significantly higher in NGT-h and NGT-l subjects compared with IGT subjects. However, in overweight subjects, first-phase insulin secretion index in NGT-h subjects was significantly lower than that in NGT-l subjects, but similar to that in IGT patients. The second-phase insulin secretion was comparable between NGT-h and NGT-l subjects. After an average follow-up of 43.80 ± 11.25 months, totally 25 (1.5 %) NGT subjects at baseline developed diabetes. The incidence rate of diabetes was higher in NGT-h overweight subjects (9.2 %) than in NGT-l overweight subjects (1.5 %) with a risk ratio (RR) reaching 6.655 [95 % confidence interval (CI) 2.347–18.867]. This risk remained after adjustment for sex, age, BMI, systolic pressure, and diastolic pressure (RR 8.315, 95 % CI 2.649–26.108). It is concluded that overweight NGT adults with high-normal 2hPG (≥125 mg/dl) had a defect in first-phase insulin secretion and were with the increasing risk for developing new diabetes.
Literature
1.
O.H. Franco, E.W. Steyerberg, F.B. Hu, J. Mackenbach, W. Nusselder, Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Arch. Intern. Med. 167(11), 1145–1151 (2007)CrossRefPubMed
2.
R.R. Holman, Assessing the potential for alpha-glucosidase inhibitors in prediabetic states. Diabetes Res. Clin. Pract. 40(Suppl), S21–S25 (1998)CrossRefPubMed
3.
S.E. Kahn, R.L. Hull, K.M. Utzschneider, Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444(7121), 840–846 (2006)CrossRefPubMed
4.
P. Boffetta, D. McLerran, Y. Chen, M. Inoue, R. Sinha, J. He, P.C. Gupta, S. Tsugane, F. Irie, A. Tamakoshi, Y.T. Gao, X.O. Shu, R. Wang, I. Tsuji, S. Kuriyama, K. Matsuo, H. Satoh, C.J. Chen, J.M. Yuan, K.Y. Yoo, H. Ahsan, W.H. Pan, D. Gu, M.S. Pednekar, S. Sasazuki, T. Sairenchi, G. Yang, Y.B. Xiang, M. Nagai, H. Tanaka, Y. Nishino, S.L. You, W.P. Koh, S.K. Park, C.Y. Shen, M. Thornquist, D. Kang, B. Rolland, Z. Feng, W. Zheng, J.D. Potter, Body mass index and diabetes in Asia: a cross-sectional pooled analysis of 900,000 individuals in the Asia cohort consortium. PLoS ONE 6(6), e19930 (2011)CrossRefPubMedCentralPubMed
5.
Y. Wang, E.B. Rimm, M.J. Stampfer, W.C. Willett, F.B. Hu, Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am. J. Clin. Nutr. 81(3), 555–563 (2005)PubMed
6.
Y. Ye, Y. Bao, X. Hou, X. Pan, H. Wu, H. Li, C. Wang, J. Tang, H. Lu, K. Xiang, W. Jia, Identification of waist circumference cutoffs for abdominal obesity in the Chinese population: a 7.8-year follow-up study in the Shanghai urban area. Int. J. Obes. (Lond.) 33(9), 1058–1062 (2009)CrossRef
7.
N. Unwin, J. Shaw, P. Zimmet, K.G. Alberti, Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet. Med. 19(9), 708–723 (2002)CrossRefPubMed
8.
T.N. Kim, M.S. Park, S.K. Lee, S.J. Yang, K.W. Lee, M. Nam, Y.S. Park, J.T. Woo, Y.S. Kim, S.H. Baik, Elevated A1C is associated with impaired early-phase insulin secretion rather than insulin resistance in Koreans at high risk for developing diabetes. Endocrine 42(3), 584–591 (2012)CrossRefPubMed
9.
J.E. Shaw, R.A. Sicree, P.Z. Zimmet, Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 87(1), 4–14 (2010)CrossRefPubMed
10.
A.G. Tabak, C. Herder, W. Rathmann, E.J. Brunner, M. Kivimaki, Prediabetes: a high-risk state for diabetes development. Lancet 379(9833), 2279–2290 (2012)CrossRefPubMedCentralPubMed
11.
C. Bianchi, R. Miccoli, M. Trombetta, F. Giorgino, S. Frontoni, E. Faloia, G. Marchesini, M.A. Dolci, F. Cavalot, G. Cavallo, F. Leonetti, R.C. Bonadonna, S. Del Prato, Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired beta-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study. J. Clin. Endocrinol. Metab. 98(5), 2100–2105 (2013)CrossRefPubMed
12.
M.A. Marini, E. Succurro, S. Frontoni, S. Mastroianni, F. Arturi, A. Sciacqua, R. Lauro, M.L. Hribal, F. Perticone, G. Sesti, Insulin sensitivity, beta-cell function, and incretin effect in individuals with elevated 1-hour postload plasma glucose levels. Diabetes Care 35(4), 868–872 (2012)CrossRefPubMedCentralPubMed
13.
M.E. Piche, S. Lemieux, L. Perusse, S.J. Weisnagel, High normal 2 h plasma glucose is associated with insulin sensitivity and secretion that may predispose to type 2 diabetes. Diabetologia 48(4), 732–740 (2005)CrossRefPubMed
14.
A. Stancakova, M. Javorsky, T. Kuulasmaa, S.M. Haffner, J. Kuusisto, M. Laakso, Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men. Diabetes 58(5), 1212–1221 (2009)CrossRefPubMedCentralPubMed
15.
C.W. Yeckel, S.E. Taksali, J. Dziura, R. Weiss, T.S. Burgert, R.S. Sherwin, W.V. Tamborlane, S. Caprio, The normal glucose tolerance continuum in obese youth: evidence for impairment in beta-cell function independent of insulin resistance. J. Clin. Endocrinol. Metab. 90(2), 747–754 (2005)CrossRefPubMed
16.
J. Hong, Y.F. Zhang, W.Q. Gu, Y.W. Zhang, Y.X. Su, Z.N. Chi, W.Q. Wang, X.Y. Li, G. Ning, Insulin sensitivity and first-phase insulin secretion in obese Chinese with hyperglycemia in 30 and/or 60 min during glucose tolerance tests. Endocrine 34(1–3), 75–80 (2008)CrossRefPubMed
17.
J.B. Su, T. Chen, F. Xu, X.Q. Wang, J.F. Chen, G. Wu, Y. Jin, X.H. Wang, Glycemic variability in normal glucose regulation subjects with elevated 1-h postload plasma glucose levels. Endocrine (2013). doi:10.​1007/​s12020-013-0047-3
18.
C. Giannini, R. Weiss, A. Cali, R. Bonadonna, N. Santoro, B. Pierpont, M. Shaw, S. Caprio, Evidence for early defects in insulin sensitivity and secretion before the onset of glucose dysregulation in obese youths: a longitudinal study. Diabetes 61(3), 606–614 (2012)CrossRefPubMedCentralPubMed
19.
R.C. Ma, J.C. Chan, Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Ann. N. Y. Acad. Sci. 1281, 64–91 (2013)CrossRefPubMedCentralPubMed
20.
V. Hjellvik, S. Sakshaug, H. Strom, Body mass index, triglycerides, glucose, and blood pressure as predictors of type 2 diabetes in a middle-aged Norwegian cohort of men and women. Clin. Epidemiol. 4, 213–224 (2012)CrossRefPubMedCentralPubMed
21.
R.N. Bergman, M. Ader, K. Huecking, G. Van Citters, Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes 51(Suppl 1), S212–S220 (2002)CrossRefPubMed
22.
S.E. Kahn, R.L. Prigeon, D.K. McCulloch, E.J. Boyko, R.N. Bergman, M.W. Schwartz, J.L. Neifing, W.K. Ward, J.C. Beard, J.P. Palmer et al., Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42(11), 1663–1672 (1993)
23.
W.P. Jia, C. Pang, L. Chen, Y.Q. Bao, J.X. Lu, H.J. Lu, J.L. Tang, Y.M. Wu, Y.H. Zuo, S.Y. Jiang, K.S. Xiang, Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities. Diabetologia 50(2), 286–292 (2007)CrossRefPubMed
24.
C. Wang, X.H. Hou, M.L. Zhang, Y.Q. Bao, Y.H. Zou, W.H. Zhong, K.S. Xiang, W.P. Jia, Comparison of body mass index with body fat percentage in the evaluation of obesity in Chinese. Biomed. Environ. Sci. 23(3), 173–179 (2010)CrossRefPubMed
25.
D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7), 412–419 (1985)CrossRefPubMed
26.
H.S. Seltzer, E.W. Allen, A.L. Herron Jr., M.T. Brennan, Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J. Clin. Invest. 46(3), 323–335 (1967)CrossRefPubMedCentralPubMed
27.
M. Stumvoll, T. Van Haeften, A. Fritsche, J. Gerich, Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care 24(4), 796–797 (2001)CrossRefPubMed
28.
M. Stumvoll, A. Mitrakou, W. Pimenta, T. Jenssen, H. Yki-Jarvinen, T. Van Haeften, W. Renn, J. Gerich, Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23(3), 295–301 (2000)CrossRefPubMed
29.
K.G. Alberti, P.Z. Zimmet, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 15(7), 539–553 (1998)CrossRefPubMed
30.
WHO expert consultation, Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363(9403), 157–163 (2004)CrossRef
31.
M. Bergman, Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus. Endocrine 43(3), 504–513 (2013)CrossRefPubMed
32.
M. Bergman, Inadequacies of current approaches to prediabetes and diabetes prevention. Endocrine 44(3), 623–633 (2013)CrossRefPubMed
33.
D. Porte Jr., S.E. Kahn, Beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms. Diabetes 50(Suppl 1), S160–S163 (2001)CrossRefPubMed
34.
S. Del Prato, A. Tiengo, The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus. Diabetes Metab. Res. Rev. 17(3), 164–174 (2001)CrossRefPubMed
35.
A.M. Cali, C.D. Man, C. Cobelli, J. Dziura, A. Seyal, M. Shaw, K. Allen, S. Chen, S. Caprio, Primary defects in beta-cell function further exacerbated by worsening of insulin resistance mark the development of impaired glucose tolerance in obese adolescents. Diabetes Care 32(3), 456–461 (2009)CrossRefPubMedCentralPubMed
36.
K. Kosaka, T. Kuzuya, R. Hagura, H. Yoshinaga, Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus. Diabet. Med. 13(9 Suppl 6), S109–S119 (1996)PubMed
37.
L. Luzi, R.A. DeFronzo, Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans. Am. J. Physiol. 257(2 Pt 1), E241–E246 (1989)PubMed
38.
C. Pang, Y.Q. Bao, C. Wang, J.X. Lu, W.P. Jia, K.S. Xiang, Relationship between the level of fasting plasma glucose and beta cell functions in Chinese with or without diabetes. Chin. Med. J. (Engl.) 121(21), 2119–2123 (2008)
39.
V. Lyssenko, P. Almgren, D. Anevski, R. Perfekt, K. Lahti, M. Nissen, B. Isomaa, B. Forsen, N. Homstrom, C. Saloranta, M.R. Taskinen, L. Groop, T. Tuomi, Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes. Diabetes 54(1), 166–174 (2005)CrossRefPubMed
40.
C. Weyer, C. Bogardus, D.M. Mott, R.E. Pratley, The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J. Clin. Invest. 104(6), 787–794 (1999)CrossRefPubMedCentralPubMed
41.
M. Hanefeld, C. Koehler, K. Fuecker, E. Henkel, F. Schaper, T. Temelkova-Kurktschiev, Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in impaired glucose tolerance for atherosclerosis and diabetes study. Diabetes Care 26(3), 868–874 (2003)CrossRefPubMed
42.
A. Festa, K. Williams, A.J. Hanley, S.M. Haffner, Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test. Diabetes 57(6), 1638–1644 (2008)CrossRefPubMed
43.
C. Meyer, W. Pimenta, H.J. Woerle, T. Van Haeften, E. Szoke, A. Mitrakou, J. Gerich, Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care 29(8), 1909–1914 (2006)CrossRefPubMed
44.
45.
R. Weiss, S.E. Taksali, W.V. Tamborlane, T.S. Burgert, M. Savoye, S. Caprio, Predictors of changes in glucose tolerance status in obese youth. Diabetes Care 28(4), 902–909 (2005)CrossRefPubMed
46.
47.
D. Gupta, C.B. Krueger, G. Lastra, Over-nutrition, obesity and insulin resistance in the development of beta-cell dysfunction. Curr. Diabetes Rev. 8(2), 76–83 (2012)CrossRefPubMed
48.
E. Ferrannini, A. Gastaldelli, Y. Miyazaki, M. Matsuda, A. Mari, R.A. DeFronzo, Beta-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J. Clin. Endocrinol. Metab. 90(1), 493–500 (2005)CrossRefPubMed
49.
J.J. Meier, T.G. Breuer, R.C. Bonadonna, A. Tannapfel, W. Uhl, W.E. Schmidt, H. Schrader, B.A. Menge, Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans. Diabetologia 55(5), 1346–1354 (2012)CrossRefPubMed
Metadata
Title
High-normal 2 h glucose is associated with defects of insulin secretion and predispose to diabetes in Chinese adults
Authors
Ziwei Lin
Jian Zhou
Xiaowen Li
Lige Song
Xuhong Hou
Junling Tang
Chen Wang
Weiping Jia
Publication date
01-02-2015
Publisher
Springer US
Published in
Endocrine / Issue 1/2015
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-014-0244-8

Other articles of this Issue 1/2015

Endocrine 1/2015 Go to the issue

Original Article

Progesterone regulation of tissue factor depends on MEK1/2 activation and requires the proline-rich site on progesterone receptor

Original Article

Thyroid hormones regulate skeletal muscle regeneration after acute injury

Original Article

Oxidative stress in patients with thyroidectomy and thyroparathyroidectomy under replacement therapy

Original Article

Insulin resistance is associated with the development of albuminuria in Korean subjects without diabetes

Research Letter

Vγ9 Vδ2 T lymphocytes activation as a novel approach to test efficacy of different bisphosphonates

Review

Epigenetic effects of paternal diet on offspring: emphasis on obesity
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits